Monday, 06 July 2020

"We have diverted resources to supply reagents for COVID-19 testing kits"- Jonathan Hunt

13 May 2020 | Views

Jonathan Hunt, Managing Director and Chief Executive Officer - Syngene International Limited talks about the company's contribution in fighting COVID-19

“I am pleased to announce solid revenue growth of 13% in the fourth quarter against a strong corresponding quarter last year. The quarter saw our two main divisions; Discovery Services and Development Services, both turn in strong performance. During the quarter, important developments included the commissioning of a new research facility in Bengaluru that will house Discovery Biology, QC Microbiology and other research capabilities. On a full year basis, we reported 10% growth in revenue over last year, which we believe provides a firm foundation to build on in the coming financial year. As India responds to the challenges of the COVID-19 pandemic, we are proud to play an active role by opening a dedicated COVID-19 testing centre to deliver antibody-based tests to support the local community and hospitals in the Bangalore region. Additionally, we have diverted resources to supply reagents for use in the development and manufacture of COVID-19 testing kits. Our scientists are also actively involved in research projects with our clients and partners to find vaccines that can make a significant contribution to combatting the COVID 19 virus.”

- Jonathan Hunt, Managing Director and Chief Executive Officer - Syngene International Limited

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account